Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay

被引:69
作者
Calaf, Raymond [1 ]
Cerini, Claire [2 ]
Genovesio, Cecile [1 ]
Verhaeghe, Pierre [7 ,8 ,9 ]
Jourde-Chiche, Noemie [2 ,3 ]
Berge-Lefranc, David [4 ]
Gondouin, Bertrand [2 ,3 ]
Dou, Laetitia [2 ]
Morange, Sophie [5 ]
Argiles, Angel [6 ]
Rathelot, Pascal [7 ,8 ,9 ]
Dignat-George, Francoise [2 ]
Brunet, Philippe [2 ,3 ]
Charpiot, Philippe [1 ,2 ]
机构
[1] Univ Mediterranee, Lab Biochim Mol Fondamentale & Clin, UFR Pharm, F-13385 Marseille 5, France
[2] Univ Mediterranee, UMR INSERM 608, UFR Pharm, F-13385 Marseille 5, France
[3] Hop Conception, AP HP, Ctr Nephrol & Transplantat Renale, F-13005 Marseille, France
[4] Univ Mediterranee, Unite Chim Phys Prevent Risques & Nuisances Techn, UFR Pharm, F-13385 Marseille 5, France
[5] Hop Conception, Ctr Invest Clin, INSERM, F-13005 Marseille, France
[6] Ecole Natl Super Chim, RD Nephrol & Grp Rein & HTA, EA3127, Inst Univ Rech Clin IURC UM1, F-34090 Montpellier, France
[7] Univ Aix Marseille 1, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
[8] Univ Aix Marseille 2, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
[9] Univ Aix Marseille 3, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 23期
关键词
Chronic kidney disease; Uremic solutes; Ion-pairing HPLC; P-CRESYL SULFATE; INDOXYL SULFATE; TOXINS; SERUM; INDUCTION; MORTALITY; CRESYLSULPHATE; PLASMA; PHENOL;
D O I
10.1016/j.jchromb.2011.06.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
During chronic kidney disease (CKD), solutes called uremic solutes, accumulate in blood and tissues of patients. We developed an HPLC method for the simultaneous determination of several uremic solutes of clinical interest in biological fluids: phenol (Pol), indole-3-acetic acid (3-IAA), p-cresol (p-C), indoxyl sulfate (3-INDS) and p-cresol sulfate (p-CS). These solutes were separated by ion-pairing HPLC using an isocratic flow and quantified with a fluorescence detection. The mean serum concentrations of 3-IAA, 3-INDS and p-CS were 2.12, 1.03 and 13.03 mu M respectively in healthy subjects, 3.21, 17.45 and 73.47 mu M in non hemodialyzed stage 3-5 CKD patients and 5.9, 81.04 and 120.54 mu M in hemodialyzed patients (stage 5D). We found no Pol and no p-C in any population. The limits of quantification for 3-IAA, 3-INDS, and p-CS were 0.83, 0.72, and 3.2 mu M respectively. The within-day CVs were between 1.23 and 3.12% for 3-IAA, 0.98 and 2% for 3-INDS, and 1.25 and 3.01% for p-CS. The between-day CVs were between 1.78 and 5.48% for 3-IAA, 1.45 and 4.54% for 3-INDS, and 1.19 and 6.36% for p-CS. This HPLC method permits the simultaneous and quick quantification of several uremic solutes for daily analysis of large numbers of samples. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:2281 / 2286
页数:6
相关论文
共 50 条
[41]   Pro: The rationale for dietary therapy for patients with advanced chronic kidney disease [J].
Kopple, Joel D. ;
Fouque, Denis .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (03) :373-378
[42]   Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease [J].
Cirstea, Stefania ;
Orzan, Olguta Anca ;
Zilisteanu, Diana Silvia .
LIFE-BASEL, 2025, 15 (07)
[43]   Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology [J].
Yaker, Linda ;
Kamel, Said ;
Ausseil, Jerome ;
Boullier, Agnes .
TOXINS, 2020, 12 (12)
[44]   Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease [J].
Addi, Tawfik ;
Dou, Laetitia ;
Burtey, Stephane .
TOXINS, 2018, 10 (10)
[45]   Uremic Toxins Activate Macrophages Implications for Atherosclerosis in Chronic Kidney Disease [J].
Hoyer, Friedrich F. ;
Nahrendorf, Matthias .
CIRCULATION, 2019, 139 (01) :97-100
[46]   Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney Disease [J].
Massy, Ziad A. ;
Liabeuf, Sophie .
EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 :8-17
[47]   Targeting protein-bound uremic toxins in chronic kidney disease [J].
Niwa, Toshimitsu .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (11) :1287-1301
[48]   Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis [J].
Akira Iguchi ;
Suguru Yamamoto ;
Akira Oda ;
Kenichi Tanaka ;
Junichiro James Kazama ;
Takako Saeki ;
Hajime Yamazaki ;
Ken Ishioka ;
Tatsuo Suzutani ;
Ichiei Narita .
Clinical and Experimental Nephrology, 2020, 24 :725-733
[49]   Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients [J].
Ito, Shunsuke ;
Yoshida, Masayuki .
TOXINS, 2014, 6 (02) :665-678
[50]   Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease [J].
Tomasz W. Kamiński ;
Krystyna Pawlak ;
Małgorzata Karbowska ;
Michał Myśliwiec ;
Dariusz Pawlak .
BMC Nephrology, 18